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Abstract: Stathmin (STMN), a microtubule-destabilizing factor, can regulate fear, anxiety, and
learning. Social defeat stress (SDS) has detrimental effects on mental health and increases the risk
of various psychiatric diseases. This study investigated the effects of STMN1 gene knockout (KO)
on behavioral parameters and dopaminergic markers using an SDS mouse model. The STMN1 KO
mice showed anxious hyperactivity, impaired object recognition, and decreased levels of neutral and
social investigating behaviors at baseline compared to wild-type (WT) mice. The impact of SDS on
neutral, social investigating and dominant behaviors differed markedly between the STMN1 WT
and KO mice. In addition, different levels of total DARPP-32 and pDARPP-32 Thr75 expression
were observed among the control, unsusceptible, and susceptible groups of STMN1 KO mice. Our
results show that STMN1 has specific roles in locomotion, object recognition, and social interactions.
Moreover, SDS had differential impacts on social interactions and dopaminergic markers between
STMN1 WT and KO mice.
Keywords: Stathmin 1; social defeat stress; novelty object recognition test; social interaction; D2
receptor isoforms; DARPP-32
1. Introduction
The stathmin (STMN) tubulin-binding proteins, including STMN1, SCG10 (STMN2), SCLIP
(STMN3), and RB3 (STMN4), are highly expressed during early postnatal brain development [1,2].
In particular, STMN1 is involved in the formation and disassembly of microtubules (MTs) [1,3]
and plays an important role in neurite outgrowth and synaptic plasticity [4]. STMN1 is a cytosolic
phosphoprotein [5] that interacts with tubulin heterodimers and prevents them from forming MTs [6].
After phosphorylation, STMN releases tubulin, allowing MT formation. In adult rodents, the highest
levels of STMN1 expression are found in the prefrontal cortex (PFC) and nucleus accumbens [7],
as well as in the lateral nucleus of the amygdala (AMY) and related thalamo-cortical structures [8].
Immunostaining showed that STMN1 was present in many of the same locations in adult humans and
rodents [9]. STMN1 was shown to be involved in processing fear in both mice [8] and humans [10].
Significant correlations between the STMN1 gene and a broad range of neuropsychiatric disorders
that involve dysfunctional neuronal networking have been reported, including neurodegenerative
disorders and schizophrenia [11,12], autism spectrum disorders, anxiety disorders [13], depression
and attention-deficit/hyperactivity disorder [14], as well as post-traumatic disorder [15,16].
Brain Sci. 2019, 9, 215; doi:10.3390/brainsci9090215 www.mdpi.com/journal/brainsci
Brain Sci. 2019, 9, 215 2 of 17
STMN knockout (KO) mice (STMN−/−) show increased MT stability in the AMY. This leads to
deficiencies in long-term potentiation (LTP) in the AMY but does not affect basal synaptic transmission
or dendritic morphology [8]. The corresponding behavioral phenotype includes deficiencies in innate
and learned responses to fear [8], as well as an enhanced fear extinction response [17], but normal pain
sensitivity and hippocampus (HIP)-dependent spatial memory in a water maze [8]. Therefore, changes
in STMN−/− mice appear to be specific to processing responses to fear in the AMY. Consequently,
STMN−/− mice are a good animal model for studying the role of the AMY in behaviors that depend on
threat or fear assessment.
Social defeat stress (SDS) is a type of social stress induced by exposure to a dominant conspecific
subject. Defeat can induce a wide range of emotional (e.g., fear, anxiety, and depression) and behavioral
abnormalities [18]. The SDS paradigm has been used widely as an animal model for depression,
anxiety disorders [19], and possibly schizophrenia [20,21]. Dopamine (DA) plays a pivotal role in
regulating threat-related emotional memory and also modulates cognitive functions, including reward,
motivation, and salience [22,23]. We considered the SDS model ideal for studying the effects of
knocking out the fear gene STMN1 on dopaminergic markers involved in processing responses to fear.
This study investigated the effects of knocking out the STMN1 gene on behavioral parameters and
dopaminergic markers using the SDS model in mice.
2. Materials and Methods
2.1. Experimental Animal
Experiments were conducted using male homozygous STMN1 KO and wild-type (WT) mice born
from heterozygous mutants (STMN1+/−) maintained on C57BL/6J background (purchased from the
Jackson laboratory (strain name: B6.129P2-STMN1tm1Wed/J; stock number: 012915). After genotyping,
mice were housed (n = 4–5 mice per cage) in a fully climate-controlled room at constant temperature
22 ± 1 ◦C, humidity on a normal 12h light/dark cycle (lights turn on 8 a.m. to 8 p.m.), and food and
water available ad libitum. All experiments were made in a strict accordance with the recommendations
in the Guidelines for animals from institutional animal care and use committee of Chonbuk national
university (IACUC) and the National Institutes of Health (NIH) principles for the Care and Use of
Laboratory Animals based on the 3Rs (replacement, refinement and reduction) and compliance with
the Animal Care Committee of Chonbuk national medical school (Approval number: CBU 2018-00213).
2.2. Study Design
Mice aged about 8–9 weeks and weighing 20–23 g were exposed to behavioral tests in order of
stress intensity (i.e., open field test, novel object recognition test, and social interaction test) before
social defeat stress for one week. After SDS for 10 days, social avoidance tests were performed at day
18. Then, same behavioral tests were performed again for one week. After 24 h from the last behavioral
test, the mice were killed by cervical dislocation and brain tissues were obtained for molecular studies
(Figure 1).
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2.3. Behavioral Measures
The following tests were performed before and after SDS: novel object recognition test (NORT),
open field test (OFT) and social interaction test (SIT). The detailed procedures were described in our
previous studies [24–26].
2.3.1. Social Defeat Stress (SDS)
Male CD-1 retired breeder mice (Central Lab Inc., Japan) were screened for aggressiveness based
on two criteria: during three 180 s screening sessions, once daily, the CD-1 mouse must attack in at
least two consecutive sessions; and the latency to initial aggression, which was recorded during each
session, must be less than 60 s [27]. C57BL/6J mice were introduced into the home cage of an unfamiliar
CD1 aggressor mouse and they were allowed to interact for 5 min. We intervened to stop serious
or prolonged confrontation. During this exposure, all subject mice were defeated and showed signs
of subordination (i.e., lying on their backs, freezing, or showing upright submissive postures). The
social defeat procedure lasted for 10 consecutive days. We checked the wounds every time after social
defeat bout. The mice with wound size greater than 1 cm were supposed to be removed based on the
recommendation by previously study [27]. One mouse was dead and two wounded mice were treated
with betadine and excluded from the experiments. After the 5 min defeat session, the experimental
mice were placed on the one side of the divider for 24 h with sensory but not physical contact. This
procedure was repeated by using a different aggressor CD1 mouse each day for 10 consecutive days.
Control mice were pair-housed in equivalent cages separated by a Plexiglas divider and never contacted
to CD1 mice. The pairing mouse was different each day.
2.3.2. Social Avoidance Test
The defeated mouse was placed in interaction box (42 × 42 cm) with an empty wire mesh cage
(10 × 4.5 cm) located at the one end. The first session was performed without CD1 mouse in the wire
mesh cage. Movement of the defeated animal was tracked for 2.5 min. After 1 min interval, a novel CD1
mouse was introduced into the wire mesh cage and the same defeated animal from first session was
placed into the box and tracked for another 2.5 min. The total time spent by the experimental mouse in
an 8 cm wide corridor surrounding the wire mesh cage (interaction zone) was automatically measured
by SMART software (Panlab, Barcelona, Spain). The interaction ratio was defined as 100 × (interaction
time with a target mouse present)/(interaction time without a target mouse present). An interaction
ratio of 100 was used as the cut-off value, where scores <100 were defined as “susceptible (Sus)” and
scores ≥ 100 as “unsusceptible (Uns)” for both WT and KO mice based on previous studies [25,28].
2.3.3. Open Field Test (OFT)
The open field test (OFT) was used to measure spontaneous locomotor activities such as locomotion
time, total distance traveled, and time spent in the central zone (defined as 25% of the total area of the
box). Automatic recording and analysis of locomotor activities were achieved in an open acrylic box
(30 × 40 × 50 cm) using a video tracking system with SMART software (Panlab, Barcelona, Spain).
2.3.4. Novel Object Recognition Test (NORT)
Novel objects recognition (NOR) was used to test non-spatial memory in rodents. Initially, mice
were habituated (10 min/day) in the empty open chamber (30 × 40 × 50 cm) under the dimly light
(20 lux) for 3 days. On day 4, mice were allowed to explore two identical objects placed in the northeast
or northwest corner approximately 10 cm from the chamber wall for 10 min during a training trial.
One hour later, mice were exposed to testing trial in which they were allowed to explore one familiar
object and one new novel object for 10 min. Mice with total exploratory times (TETs) of <5 s per
object [29], or showing more than a 30% difference between two objects within 10 min during training
trials, were excluded. The recognition index (RI) was the time that animals spent with the novel object
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(TN) divided by the total time spent exploring the familiar objects (TF) and TN in the testing trial (i.e.,
RI = TN/(TN + TF)).
2.3.5. Social Interaction Test
A C57BL/6J mouse was paired with an unfamiliar CD1 male mouse and their behaviors were
recorded for 10 min under dim light (40 lux). Male CD1 mice, aged 4–5 weeks, had a similar weight
to experiment mice. The time the experiment mouse spent interacting with the CD1 mouse was
manually scored. The following four categories of behaviors were analyzed: neutral (rearing, cage or
air sniffing, and self-grooming), social (social grooming/sniffing, nose sniffing, anogenital sniffing, and
following/approaching), dominant (attacks, bites, aggressive chasing, climbing, mounting, upright or
sideways offensive posture, aggressive grooming and tail rattling) and submissive behaviors (upright
or sideways defensive posture, crouching, upright or sideways submissive posture, full submission
posture, passive anogenital sniffing or being sniffed at the body part, avoidance, and curling up in the
corner and remaining motionless).
2.4. Immunohistochemistry (IHC)
After perfusion and fixation, free-floating tissue sections were treated with peroxidase-blocking
solution (S2023, Dako, Glostrup, Denmark) and incubated in protein-blocking solution (X0909, Dako).
The sections were incubated with a primary antibody against STMN1 (1:200, ab52630; Abcam,
Cambridge, UK) and biotinylated secondary antibodies (1:200, E0466; Dako). After washing with
phosphate buffered saline, sections were placed in streptavidin-horseradish peroxidase solution (1:200,
P0397; Dako) and incubated with the chromogen AEC (3-amino-9-ethylcarbazole, K3461, Dako).
2.5. Western Blotting
2.5.1. Preparation of Brain Tissue for Western Blot
After brain extraction, target regions were immediately dissected out on an ice plate according to
the Bregma zero coordinates: Amygdala (AMY, −1.05~−2 mm), dorsal striatum (dST, +1.04~−1.46 mm),
hippocampus (HIP, −1.5~−2.18 mm) and prefrontal cortex (PFC, +1.54~+1.98 mm) [30] by a 1.0-mm
Harris Uni-Core micro-punch (Electron Microscopy Sciences; Hatfield, PA 19440, USA). Bilateral
punches tissues were pooled from each mouse. Each tissue sample was quickly cryopreserved in
liquid nitrogen and stored at −80 ◦C until assay.
2.5.2. Total STMN1 and STMN1 Phosphorylated at Serine 16 (pS16-STMN1)
After tissue homogenization, protein samples (20 µg) were loaded onto 12% polyacrylamide
gels. After transfer, the membranes were treated with 0.25% glutaraldehyde at room temperature for
10 min in 0.2% Tween 20/tris-buffered saline (TTBS) to crosslink tissue proteins that might destroy or
mask immunogenic epitopes within the tissue [31,32]. The membranes were then blocked with 5%
skimmed milk and incubated with a rabbit monoclonal antibody against STMN1 (ab52630; Abcam)
diluted 1:50,000, and with a rabbit polyclonal antibody phosphorylated at S-16 (3353; Cell Signaling
Technology, Danvers, MA, USA) and diluted 1:1000 at 4◦C overnight. After washing five times with
TTBS, the membranes were incubated with peroxidase-labeled goat anti-rabbit IgG (H + L) (Vector
Laboratories, Burlingame, CA, USA) diluted 1:5000 at room temperature for 2 h.
2.5.3. Short (D2S) and Long (D2L) Forms of The Dopamine D2 Receptor (D2R)
Two isoforms of the D2R, D2L and D2S have been analyzed previously and a few modifications
were observed [33,34]. A detailed description of this analysis was reported in our previous study [26].
Glutaraldehyde-treated membranes were incubated in 5% skimmed milk overnight at 4 ◦C with rabbit
polyclonal antibodies against D2L (1:2000) and D2S (1:5000) (AbClon, Inc., Seoul, Korea). After the
membranes were washed three times, the primary antibodies were detected using peroxidase-labeled
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goat anti-rabbit IgG (H + L) (1:3000 for D2L and 1:5000 for D2S; Vector Laboratories) for 2 h at room
temperature (25 ◦C).
2.5.4. Total Dopamine- and Cyclic Adenosine 3′,5′-Monophosphate-regulated phosphoprotein-32
(DARPP-32), DARPP-32 Phosphorylated at Threonine 34 (pDARPP-32 Thr34), and DARPP-32
Phosphorylated at Threonine 75 (pDARPP-32 Thr75)
Blocked membranes were incubated with the primary antibody, which was rabbit monoclonal total
DARPP-32 (1:50,000; Abcam), rabbit monoclonal pDARPP-32 Thr34 (1:1000; Cell Signaling Technology),
or rabbit polyclonal pDARPP-32 Thr75 (1:1000; Cell Signaling Technology). After washing three times
with TTBS, the primary antibodies were detected using peroxidase-labeled goat anti-rabbit IgG (H + L)
antibodies (1:5000; Vector Laboratories) for 2 h at room temperature (25 ◦C).
2.6. Statistical Analysis
Results were expressed as means ± standard error. The behavioral data were analyzed using
two-way analysis of variance (ANOVA) with genotype and group (control, unsusceptible, and
susceptible) as the main effects and the change (subtraction of the values after stress from the values
before stress) as the dependent variable. If an interaction or main effect was significant, appropriate
pairwise comparisons were performed using Tukey’s honest significant difference test. For Western
blotting, initial sample sizes were randomly reduced to include 8–15 per group. In addition, the
data showing consistent patterns with duplicate were only used for analysis. One-way ANOVA was
used to compare groups from each genotype on the Western blots because we could not run all 12
samples (6 groups in duplicate) from two genotypes on a single gel due to difficulties in adjusting
the experimental schedule. Fisher’s least-significant-difference post hoc tests were used to validate
significant results. In order to confirm STMN1 gene knock out, two mice from each group of the WT mice
and two mice from control group of the KO mice were randomly selected for immunohistochemistry
(IHC). Statistical analyses were performed using R software (ver. 3.5.3; R Development Core Team,
Vienna, Austria). In all cases, a p-value < 0.05 was considered statistically significant.
3. Results
3.1. Social Avoidance Test (Table 1)
The proportions of unsusceptible and susceptible mice were not significantly different between
the WT and KO mice (p = 0.561): 13 (44.83%) unsusceptible and 16 (55.17%) susceptible mice among
the WT mice and 12 (37.50%) unsusceptible and 20 (62.50%) susceptible mice among the STMN1 KO
mice. For social interaction ratio, two-way ANOVA revealed significant genotype × group interaction
(F2,79 = 3.521, p = 0.034, post hoc tests: WT-Con vs. WT-Sus, p < 0.001; WT-Uns vs. WT-Sus, p < 0.001;
KO-Con vs. KO-Sus, p < 0.001; KO-Uns vs. KO-Sus, p < 0.001) and main effect of group (F2,79 =
129.737, p < 0.001, post hoc tests: Con vs. Sus, p < 0.001; Uns vs. Sus, p < 0.001) but no significant effect
of genotype (F1,79 = 0.443, p > 0.05). For the corner ratio, two-way ANOVA showed no significant
genotype × group interaction and main effect of genotype but a significant main effect of group (F2,79 =
17.450, p < 0.001, post hoc tests: Con vs. Sus, p < 0.001; Uns vs. Sus, p < 0.001).
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Table 1. Results of two-way analysis of variance (ANOVA) for social avoidance.
Parameter Group WT KO p a Group Genotype Genotype ×Group
Social
Interaction
ratio
Con 124.247 ± 12.1 146.994 ± 14.6 0.242 F2,79 = 129.737,
p < 0.001
F1,79 = 0.443,
p = 0.507
F2,79 = 3.521,
p = 0.034Uns 156.088 ± 13.9 165.356 ± 17.3 0.689
Sus 40.986 ± 6.48 22.175 ± 3.19 0.016
Corner ratio
Con 0.718 ± 0.179 0.675 ± 0.0962 0.836 F2,79 = 17.450,
p < 0.001
F1,79 = 0.942,
p = 0.335
F2,79 = 1.599,
p = 0.209Uns 0.938 ± 0.279 1.194 ± 0.334 0.562
Sus 5.689 ± 1.13 3.808 ± 0.889 0.204
Data were expressed in mean ± S.E.M; a comparison between WT and KO mice by unpaired t test. Con, Control;
KO, Knock Out; Sus, Susceptible; Uns, Unsusceptible; WT, Wild-Type.
3.2. Open Field Test (Figure 2)
As for the total distance travelled before stress, two-way ANOVA revealed no significant genotype
× group interaction (F2,80 = 0.879, p > 0.05) but significant main effects of genotype (F1,80 = 90.747,
p < 0.001) and group (F2,80 = 3.397, p = 0.038, post hoc test: Con vs. Uns, p = 0.012). After stress, it
showed significant genotype × group interaction (F2,80 = 3.372, p = 0.039, post hoc tests: WT-Uns vs.
KO-Uns, p < 0.001; WT-Sus vs. KO-Sus, p = 0.002) and significant main effect of genotype (F1,80 =
36.472, p < 0.001) but no significant main effect of group (F2,80 = 1.838, p > 0.05). For the change, there
were no significant genotype × group interaction (F2,80 = 1.270, p > 0.05) and main effect of genotype
(F1,80 = 3.180, p = 0.078) but a significant main effect of group (F2,80 = 4.155, p = 0.019, post hoc tests:
Con vs. Uns, p = 0.039; Con vs. Sus, p = 0.025). As for the locomotion time before stress, two-way
ANOVA revealed no significant genotype × group interaction (F2,80 = 1.741, p > 0.05) and main effect
of group (F2,80 = 1.703, p > 0.05) but a significant main effect of genotype (F1,80 = 57.076, p < 0.001).
After stress, it showed significant genotype × group interaction (F2,80 = 3.977, p = 0.022, post hoc tests:
WT-Uns vs. KO-Uns, p < 0.001; WT-Sus vs. KO-Sus, p < 0.001) and main effect of genotype (F1,80 =
39.208, p < 0.001) but no significant main effect of group (F2,80 = 2.009, p > 0.05). For the change, there
were no significant genotype × group interactions (F2,80 = 2.738, p = 0.070) and main effects of genotype
(F1,80 = 0.126, p > 0.05) and group (F2,80 = 2.856, p = 0.063). As for the time spent in the central zone
before stress, two-way ANOVA revealed no significant genotype × group interaction (F2,79 = 0.439,
p > 0.05) and main effect of group (F2,79 = 1.410, p > 0.05) but a significant main effect of genotype (F1,79
= 12.573, p < 0.001). After stress, it showed no significant genotype × group interaction (F2,79 = 0.837,
p > 0.05) and main effect of group (F2,79 = 1.564, p > 0.05) but a significant main effect of genotype (F1,79
= 15.682, p < 0.001). For the change, there were no significant genotype × group interaction (F2,79 =
0.883, p > 0.05) and main effects of genotype (F1,79 = 0.920, p > 0.05) and group (F2,79 = 0.377, p > 0.05).
In the additional analysis (Supplementary Table S1), baseline locomotor activities (distance
traveled and locomotion time) were significantly higher in all three groups of KO mice compared to
those of WT mice whereas time spent in central zone was significantly lesser in KO mice compared to
WT mice. Comparison of the change between the genotypes showed significant difference only in
control group for the distance traveled.
3.3. Novel Object Recognition Test (Figure 3)
As for the recognition index before stress, two-way ANOVA revealed no significant genotype
× group interaction (F2,80 = 0.613, p > 0.05) and main effect of group (F2,80 = 0.086, p > 0.05) but a
significant main effect of genotype (F1,80 = 15.263, p < 0.001). Genotype difference was also confirmed
in the additional analysis (Supplementary Table S2). After stress, it showed no significant genotype
× group interaction (F2,80 = 1.085, p > 0.05) but significant main effects of genotype (F1,80 = 14.573,
p < 0.001) and group (F2,80 = 5.114, p = 0.008, post hoc tests: Con vs. Uns, p = 0.012; Con vs. Sus,
p = 0.010). For the change, there were no significant genotype × group interaction (F2,80 = 0.281,
p > 0.05) and main effect of genotype (F1,80 = 0.213, p > 0.05) but a significant main effect of group (F2,80
= 3.241, p = 0.044, post hoc tests: no significant results).
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Figure 3. Effect of social defeat on the recognition index (RI) of the novel object recognition test (NORT).
*** p < 0.001 for main effect of genotype; # p < 0.05, ## p < 0.01 for main effect of group; Con, Control;
KO, Knock ut; Sus, Susceptible; Uns, Unsusceptible; WT, Wild-Type.
3.4. Social Interaction Test (Figure 4)
As for the neutral behaviors before stress, two-way ANOVA revealed significant genotype ×
group interaction (F2,80 = 12.998, p < 0.001, post hoc tests: WT-Uns vs. KO-Uns, p < 0.001; WT-Sus
vs. KO-Sus, p < 0.001; WT-Con vs. WT-Sus, p = 0.032; KO-Con vs. KO-Uns, p = 0.002; KO-Con vs.
KO-Sus, p = 0.005) and main effect of genotype (F1,80 = 63.272, p < 0.001) but no significant main effect
of group (F2,80 = 0.729, p > 0.05). After stress, it showed no significant genotype × group interaction
(F2,80 = 1.591, p > 0.05) but significant main effects of genotype (F1,80 = 19.089, p < 0.001) and group
(F2,80 = 11.385, p < 0.001, post hoc tests: Con vs. Uns, p = 0.007; Con vs. Sus, p < 0.001). For the change,
there were significant genotype × group interaction (F2,80 = 9.183, p < 0.001, post hoc tests: WT-Uns vs.
KO-Uns, p < 0.001; WT-Sus vs. KO-Sus, p < 0.001; WT-Con vs. WT-Sus, p < 0.001) and main effects of
genotype (F1,80 = 86.876, p < 0.001) and group (F2,80 = 3.223, p = 0.045, post hoc tests: Con vs. Sus,
p = 0.013). Comparison of the change of neutral behaviors between the genotypes revealed significant
differences in the Uns and Sus groups (Supplementary Table S3).
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Figure 4. Effects of social defeat on social interaction: ( ) neutral behavior, (B) social investigating
behaviors, (C) do inant behaviors, (D) submissive behaviors. * p < 0.05, ** p < 0.01, *** p < 0.001
for main effect of genotype; # p < 0.05, ## p < 0.01, ### p < 0.001 for main effect of group; p < 0.05,
++ p < 0.01, +++ p < 0.001 for post hoc results of significant interaction; Con, Control; KO, Knock Out;
Sus, Susceptible; Uns, Unsusceptible; T, Wild-Type.
For the social in ti f r tress, t o- ay ANOVA revealed no significant
genotype × ( 2,80 = 0.269, p > 0.05) and main ffect of group (F2,80 = 0.052, p > 0.05)
but a significant main ffect of genotype (F1,80 = 12.912, p < 0.001). After stress, it showed no sign ficant
genotype × group interaction (F2,80 1.424, 0.05) and ain eff ct f t ( 1,80 = 0.086, p > .05)
but a significant main effect of group (F2,80 . , 0.01, ost hoc tests: Con vs. Uns, p = 0.038; Con
vs. Sus, p < 0.001). r t e c a e, t ere as si ifica t e t e r i teracti ( 2,80 = 1.263,
p > 0.05) b t significant ain effects of genotype (F1,80 = 10.817, p = 0.001) and group (F1,80 = 4.123,
p = 0.019, post hoc test: Con vs. Sus, p < 0.013).
For the dominant behaviors before stress, two-way ANOVA revealed no significant genotype
× group interaction (F2,78 = 0.393, p > 0.05) and main effect of group (F2,78 = 2.418, p = 0.095) but a
significant main effect of genotype (F1,78 = 5.673, p = 0.019). After stress, it showed no significant
genotype × group interaction (F2,78 = 1.071, p > 0.05) and main effects of genotype (F1,78 = 2.166,
p > 0.05) and group (F2,78 = 0.940, p > 0.05). For the change, there was no significant genotype × group
interaction (F2,78 = 2.016, p > 0.05) but significant main effects of genotype (F1,78 = 5.221, p = 0.025) and
group (F2,78 = 4.352, p = 0.016, post hoc test: Con vs. Uns, p = 0.012). Comparison of the changes of
social investigating and dominant behaviors between the genotypes revealed significant differences
only in the Sus group (Supplementary Table S3).
For the submissive behaviors before stress, two-way ANOVA revealed no significant genotype
× group interaction (F2,79 = 2.022, p > 0.05) and main effects of genotype (F1,79 = 0.952, p > 0.05) and
group (F2,79 = 0.056, p > 0.05). After stress, it showed no significant genotype × group interaction (F2,79
= 0.150, p > 0.05) but significant main effects of genotype (F1,79 = 7.506, p = 0.007) and group (F2,79
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= 4.917, p = 0.009, post hoc tests: Con vs. Uns, p = 0.007). For the change, there were no significant
genotype × group interaction (F2,79 = 0.153, p > 0.05) and main effect of genotype (F1,79 = 2.279, p > 0.05)
but a significant main effect of group (F2,79 = 3.402, p = 0.04, post hoc tests: no significant results).
3.5. Immunohistochemistry (Figure 5C)
STMN1 immunoreactivity was strong in the PFC, HIP, and AMY, but weak in the dST, of the WT
mice. No STMN1 immunoreactivity neurons were found in the STMN1 KO mice.
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Figure 5. Western blot and immunohistochemistry (IHC) results of stathmin 1 (STMN1) among
three groups of STMN1 WT mice. (A) Total—STMN1 and (B) pS16—STMN1. (C) Representative
Immunohistochemistry staining images of anti-stathmin 1 (red) in the prefrontal cortex (PFC), dorsal
hippocampus (HIP), amygdala (AMY) and dorsal striatum (dST) of WT control. No signal was detected
in the KO control in all regions. Scale bar, 50 µm. * p < 0.05 for main effect of genotype; Con, Control;
KO, Knock Out; Sus, Susceptible; Uns, Unsusceptible; WT, Wild-Type.
3.6. Western Blotting
Expression of STMN1 protein was absent in the STMN1 KO mice (data not shown). There were no
significant differences of total STMN1 expression levels in PFC, HIP, AMY, and dST among the control,
unsusceptible, and susceptible WT mice groups. However, significant difference of pS16-STMN1 levels
among the three groups was found in the PFC (F2,30 = 3.632, p = 0.038). The post-hoc tests showed a
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significance toward lower expression levels in the unsusceptible (p = 0.02) and susceptible (p = 0.03)
groups compared to control group (Figure 5B).
Regarding D2S and D2L, there were trends toward altered levels of D2S in the PFC (F2,23 = 3.358,
p = 0.052) and D2L in the AMY (F2,26 = 3.207, p = 0.056) among the three WT groups. In the STMN1
KO mice, there were trends toward altered levels of D2S in the PFC (F2,35= 3.005, p = 0.062) and dST
(F2,25 = 3.077, p = 0.063) among the three groups (Figure 6). For the DARPP-32 expressions in WT mice,
significant difference among the three groups was shown only for pDARPP-32 Thr75 in the PFC (F2,21
= 6.841, p = 0.005). The post hoc tests revealed significantly higher expression in the unsusceptible
group than in the control group (p = 0.001). In the STMN1 KO mice, there were significant differences
among the three groups for total DARPP-32 in the AMY (F2,36 = 5.387, p = 0.008) and dST (F2,35 = 4.723,
p = 0.015). The post hoc tests for total DARPP-32 showed significantly higher expressions in the AMY
of the unsusceptible (p = 0.018) and susceptible (p = 0.003) groups compared to the control group, and
in the dST of the susceptible group compared to the control group (p = 0.004). For pDARPP-32 Thr75
expression in KO mice, significant difference was only found in the PFC (F2,36 = 6.943, p = 0.002). The
post hoc tests showed significantly higher expressions in the unsusceptible (p = 0.002) and susceptible
(p = 0.002) groups compared to the control group (Figure 7).
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Figure 6. Western blot results of dopamine isoform among three groups in STMN WT and KO mice.
(A) D2S: expression levels of total D2S in the PFC, HIP, AMY and dST; and (B) D2L: expression levels
of total D2L in the PFC, HIP, AMY and dST. Con, Control; KO, Knock Out; Sus, Susceptible; Uns,
Unsusceptible; WT, Wild-Type.
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Figure 7. Western blot results of DARPP-32 among three groups in STMN KO and WT mice. (A) Total
DARPP-32: expression levels of total DARPP-32 in the PFC, HIP, AMY and dST of WT and KO mice;
(B) pDARPP-32 Thr34: expression levels of pDARPP-32 Thr34 in the PFC, HIP, AMY and dST of WT
and KO mice; and (C) pDARPP-32 Thr75: expression levels of pDARPP-32 Thr75 in the PFC, HIP, AMY
and dST of WT and KO mice. * p < 0.05, ** p < 0.01 compared to control group; Con, Control; KO,
Knock Out; Sus, Susceptible; Uns, Unsusceptible; WT, Wild-Type.
4. Discussion
The STMN1 gene, known as a fear gene, is an MT-destabilizing phosphoprotein. It is implicated
in neurite growth, synaptic plasticity, and the pathophysiology of various neuropsychiatric disorders.
We investigated the impacts of STMN1 KO on behavioral parameters and dopaminergic markers
using a mouse model of SDS. Our findings suggest that STMN1 KO mice have unique behavioral
characteristics (e.g., locomotor activities, capacity for recognition, and social interactions) at baseline
and show different responses to SDS, in terms of social interactions and dopaminergic markers,
compared to WT mice.
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4.1. Effects of Stathmin 1 Gene Knockout on Behaviors
Before stress, we found significant a main effect of genotype for locomotor activities, NORT and
social interaction behaviors (neutral, social investigation and dominant behaviors). Firstly, the results
with OFT suggest that STMN1 KO mice display higher levels of distance traveled and locomotion time
and less time spent in the central zone. In the OFT, an animal’s tendency to avoid the center of an
arena is considered anxiety-related because the arena center is more threatening than its periphery,
and because the administration of anxiolytic drugs increases the likelihood that an animal will occupy
the center of the arena [35]. Therefore, these results suggest that STMN1 KO mice show hyperactivity
but are also affected by anxiety. Secondly, the results with NORT indicate that STMN1 KO mice have
lower RIs than STMN1 WT mice. This suggests the presence of cognitive impairment in STMN1 KO
mice, which contrasts with reports that STMN-deficient mice showed normal HIP-dependent spatial
memory in a water maze [8]. It should be noted that the Morris water maze test involves a stressful
stimulus to ensure that animals are motivated to perform the task, whereas the NORT is based on the
natural tendency of mice to spend more time exploring an unknown object than a familiar one [36].
STMN1 KO mice tend to show subtle cognitive impairments that are only detectable using spontaneous
behavior-driven tests. Thirdly, the results with SIT suggest that STMN1 KO mice display significantly
reduced neutral and social investigating behaviors, and increased dominant behaviors compared to
WT mice. Rearing is regarded as a useful marker for environmental novelty [37] and self-grooming is a
sensitive marker for anxiety and stress levels [38]. Social investigating behaviors are also a measure
of social anxiety and preference of engagement in social behaviors. Therefore, these findings may
indicate that STMN1 KO mice do not feel the need to explore their environment or are less vigilant,
and experience significant social stress. Taken together, the results with behavioral tests suggest that
STMN1 KO mice show anxious hyperactive behaviors and deficiencies in cognitive function and social
interactions. These results contrast with the observation that STMN1 KO mice develop normally and
show no obvious disorders [39].
Regarding the changes induced by SDS, we observed a significant main effect of the group for
all behavioral tests, but a significant main effect of genotype was only found for SIT (neutral, social
investigating and dominant behaviors). These results suggest that after SDS, effect of STMN1 KO
remains specific to social interacting behaviors, not to locomotion and memory. More specifically,
STMN1 WT mice showed decreased changes of neutral, social investigating and dominant behaviors
whereas STMN1 KO mice demonstrated lesser changes in social interacting and dominant behaviors
and even increased change in neutral behavior. These findings may suggest that STMN1 KO mice
are more resistant to the negative effects of SDS on social interaction. The molecular mechanism
underlying this resilience to stress may be that STMN1 deficiency increases MT stability in the AMY,
leading to deficiencies in LTP in response to fear induced by defeat stress [8].
4.2. Effects of Social Defeat Stress on Stathmin Expression
SDS induced no significant difference in total STMN1 expression among the four brain regions in
the control, unsusceptible, and susceptible groups of WT mice. STMN1 expression in the AMY and HIP
reportedly decreased after a single prolonged stress treatment and immobilization stress in rats [40].
In contrast, pS16-STMN1 expression levels significantly decreased in the PFC of unsusceptible and
susceptible groups of WT mice compared to the control group. Phosphorylation of Ser16 or Ser63
appears to be more critical than phosphorylation of Ser25 and Ser38 for the ability of stathmin to bind
to soluble tubulin and to inhibit MT assembly in vitro [41,42]. Based on this observation, we focused
our work on pS16-STMN1 expression. Phosphorylation at either Ser16 or Ser63 strongly reduces or
abolishes the ability of stathmin to bind to and sequester soluble tubulin resulting in increased MT
stability [43]. Increased MT stability is known to contribute to axonal growth, synaptic plasticity,
neuronal differentiation and memory [44]. In contrast, dephosphorylation of stathmin at Ser16 has been
reported to restrain microtubule polymerization and result in regression of neuronal dendrites [45–47].
Taken together, our findings may be interpreted that decreased pS16-STMN1 expression induced
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by SDS may lead to inhibiting MT stabilizing activity and cause impairment of axonal transport
and synaptic activity. These mechanisms may be associated with various behavioral and molecular
abnormalities reported in defeated mice.
4.3. Effects of Stathmin 1 Gene Knockout on Dopaminergic Markers
Following SDS, there was a change in the trends of D2S and D2L expression. In particular, STMN1
WT and KO mice displayed contrasting changes in D2S expression levels in the PFC. The WT mice
in the susceptible group showed increased expression compared to the control group, and STMN1
KO mice in the susceptible group showed decreased expression compared to the control group. This
finding may be related to the different impacts that SDS has on social interactions, especially social
investigation behaviors, between WT and KO mice. A significant difference in the expression of total
DARPP-32 among the three groups was only observed in the STMN1 KO mice. Several studies have
reported changes in total DARPP-32 expression in rodents after an inhibitory avoidance task [48] and
caloric restriction [49]. A functional link has been reported between the microtubule cytoskeleton
and dopamine transporter (DAT) [50]. Hence, possible interpretation for the changes of D2S and
total DARPP-32 expression in the STMN1 KO mice may be due to the interaction between stathmin
and DAT. Interestingly, the level of pDARPP-32 Thr34 was not changed, but the level of pDARPP-32
Thr75 was significantly increased in the PFC of defeated groups of WT and STMN1 KO mice. Possible
mechanisms may be speculated as follows (Figure 8). Dopamine (DA) released in response to SDS
may bind to D1 receptors and increase pDARPP-32 Thr34 via protein kinase A (PKA) activation. At
the same time, DA may bind to D2 receptors and increase pDARPP-32 Thr75 via cyclin-dependent
kinase 5 (Cdk 5) activation 5 [51]. This also leads to reduction of pDARPP-32 Thr34 via inhibition of
PKA. Given that D1 receptor expression was reduced in the frontal cortex of defeated mice [52], a net
effect on pDARPP-32 Thr34 would be zero or inhibition. As reduction of pDARPP-32 Thr34 can lead to
increased activation of PP-1 [51,53,54] and stathmin at Ser16 is known to be dephosphorylated by PP-1,
PP-2A, and PP-2B [55,56], the final effect of SDS would lead to decrease of pSTMN-16 in the PFC of
defeated mice. Understanding how these changes in DARPP-32 may be related to different behavioral
profiles at baseline and after defeat stress in STMN1 WT and KO mice will require further research.
4.4. Limitations
This study had several limitations. First, given that STMN1 is a cytosolic phosphoprotein,
measurement of protein expression using more specific subcellular fraction would have given different
results. This should be considered in designing future study. Second, conditioned fear is reported
to causes time-dependent biphasic changes in the phosphorylation of STMN at Ser16, Ser25, and
Ser38 in the dentate gyrus [57]. This finding suggests that phosphorylation levels may change at
different time points. Hence, measurement at multiple time points would give more dynamic features.
Third, although the behavioral experiment was conducted simultaneously with both genotypes, in the
Western blotting experiment we ran the samples on separate gels from both genotypes. Therefore, we
were unable to directly compare the Western blotting results between the STMN1 WT and KO mice.
Strength of this study was that we evaluated various behavioral profiles of the STMN1 KO adult mice
extensively before and after stress, together with the unique impacts that SDS had on dopaminergic
markers in key regions of the brain implicated in neuropsychiatric disorders. In humans, fear and
anxiety as well as cognitive and affective control processing were shown to be associated with STMN1
polymorphisms [10,14]. An increasing number of correlations are being reported between the STMN1
gene and a broad range of neuropsychiatric disorders such as schizophrenia [11,12] and depression
and attention-deficit/hyperactivity disorder [14]. Exploring the mechanisms of association between
STMN1 KO and altered behavioral and dopaminergic markers would help identify target molecules
for the treatment of neuropsychiatric disorders.
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Several studies have reported changes in total DARPP-32 expression in rodents after an inhibitory 
avoidance task [48] and caloric restriction [49]. A functional link has been reported between the 
microtubule cytoskeleton and dopamine transporter (DAT) [50]. Hence, possible interpretation for 
the changes of D2S and total DARPP-32 expression in the STMN1 KO mice may be due to the 
interaction between stathmin and DAT. Interestingly, the level of pDARPP-32 Thr34 was not 
changed, but the level of pDARPP-32 Thr75 was significantly increased in the PFC of defeated groups 
of WT and STMN1 KO mice. Possible mechanisms may be speculated as follows (Figure 8). Dopamine 
(DA) released in response to SDS may bind to D1 receptors and increase pDARPP-32 Thr34 via 
protein kinase A (PKA) activation. At the same time, DA may bind to D2 receptors and increase 
pDARPP-32 Thr75 via cyclin-dependent kinase 5 (Cdk 5) activation 5 [51]. This also leads to reduction 
of pDARPP-32 Thr34 via inhibition of PKA. Given that D1 receptor expression was reduced in the 
frontal cortex of defeated mice [52], a net effect on pDARPP-32 Thr34 would be zero or inhibition. As 
reduction of pDARPP-32 Thr34 can lead to increased activation of PP-1 [51,53,54] and stathmin at 
Ser16 is known to be dephosphorylated by PP-1, PP-2A, and PP-2B [55,56], the final effect of SDS 
would lead to decrease of pSTMN-16 in the PFC of defeated mice. Understanding how these changes 
in DARPP-3  may be related to different behavioral profiles at baseline and after defeat stress in 
STMN1 WT and KO mice will require further research.  
 
 
Figure 8. Mechanisms illustrating how social defeat stress may affect expression of pDARPP-32 Thr34, 
pDARPP-32 Thr75 and pSTMN-16. 
Figure 8. Mechanisms illustrating how social defeat stress may affect expression of pDARP -32 Thr34,
pDARP -32 Thr75 and pSTMN-16.
5. Conclusions
In conclusion, our findings indicate that STMN1 KO mice display anxious hyperactivity, impaired
recognition, and decreased levels of neutral behavior at baseline compared to WT mice. The impacts of
SDS on neutral, social investigating and dominant behaviors differed markedly between the STMN1
WT and KO mice. In addition, different levels of total DARPP-32 and pDARPP-32 Thr75 expression
were observed among the control, unsusceptible, and susceptible groups of STMN1 KO mice.
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